Log In
Print this Print this

DaxibotulinumtoxinA Topical Gel (RT001, RTT150)

  Manage Alerts
Collapse Summary General Information
Company Revance Therapeutics Inc.
DescriptionTopical gel formulation of botulinum toxin type A that uses TransMTS technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today